Navigation

Vergangene Vorträge

Hier finden Sie eine Übersicht aller Vorträge innerhalb der Vortragsreihe (Immunologisches Kolloquium) des Medical Immunology Campus Erlangen

07.01.2020
Dr. Silvia Portugal
Department of Infectious Diseases, Parasitology, Heidelberg University Hospital
„Plasmodium falciparum dry season reservoir: a long hide and seek game“

14.01.2020
PD Dr. Marta Rizzi
Klinik für Rheumatologie und Klinische Immunologie, Universitätsklinikum Freiburg
„To B or not to B: developmental decisions in human B cells“

21.01.2020
Prof. Christopher Linington
Institute of Infection, Immunity & Inflammation, University of Glasgow, UK
„Antibody-mediated activation of microglia: a generalised treatment strategy for viral encephalitis“

28.01.2020
Dr. Elodie Segura
INSERM, Institut Curie, Centre d’Immunothérapie, Paris, France
„Functional specialization of human dendritic cell subsets“

04.02.2020
Dr. Christoph Klose
Charité – Universitätsmedizin Berlin
„Immune regulation at barrier surfaces by group 2 innate lymphoid cells“

03.03.2020
Dr. Sebastian Winter
Department of Microbiology, UT Southwestern Medical Center; Dallas, TX, USA
“Gut Microbiota Metabolism during Health and Disease”

28.04.2020
Dr. Linda Sinclair
Division of Cell Signalling and Immunology , School of Life Sciences, University of Dundee, UK
“Nutrient transport in T cells”

26.05.2020
Dr. Jan Böttcher
Institute of Molecular Immunology and Experimental Oncology, Technische Universität München
„Orchestration of anti-cancer immunity by dendritic cells“

02.06.2020
Jason McLellan, PhD
The University of Texas at Austin, TX, USA
“Development of Vaccines and Nanobodies for SARS-CoV-2”

09.06.2020
Dr. Joan Yuan
Division of Molecular Hematology,
Lund University, Lund, Schweden
„Developmental timing imparts distinct B cell responses in vivo“

16.06.2020
Dr. Victor Greiff
University of Oslo, Department of Immunology, Oslo, Norwegen
„Quantifying the specificity of the adaptive immune response on the repertoire and sequence level“

30.06.2020
Prof. Hergen Spits
Amsterdam Infection & Immunity Institute, Amsterdam, Niederlande
„Development, function and plasticity of Human ILC2“

08.01.2019
Prof. Sven Hammerschmidt
Department of Molecular Genetics and Infection Biology, Universität Greifswald
„Function and immunogenicity of Streptococcus pneumoniae surface proteins“

22.01.2019
Prof. Joachim Hauber
Heinrich-Pette-Institut, Leibniz-Institut für Experimentelle Virologie, Hamburg
„Antiviral Therapy of Persistent Viral Infection using Genome Editing”

29.01.2019
PD Dr. Isis Ludwig-Portugall
Institut für experimentelle Immunologie (IEI), Uniklinik Bonn
„Innate lymphocytes (ILCs) respond to crystal-deposition and promote local inflammation and fibrosis“

05.02.2019
Prof. Philip Rosenstiel
Institut für Klinische Molekularbiologie, Christian-Albrechts-Universität zu Kiel
„Mechanisms of homeostasis at the intestinal barrier“

30.04.2019
Prof. Holger Hackstein
Transfusionsmedizinische und Hämostaseologische Abteilung in der Chirurgischen Klinik, Uniklinikum Erlangen
„ADAR1 and dendritic cells“

07.05.2019
Prof. Carl Figdor
Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands
„21st century cancer vaccines“

14.05.2019
Prof. Anne Dudeck
Institut für Molekulare und Klinische Immunologie, Otto-von-Guericke-Universität Magdeburg
„Titel wird noch bekannt gegeben“

21.05.2019
Prof. Erwin Wagner
Centro Nacional de Investigaciones, Oncológicas (CNIO), Madrid, Spain
„Innate immune signaling in Inflammatory Skin/Joint Disease and Lung Fibrosis“

22.05.2019
Sonderseminar – Dr. Stefan Uderhardt
Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, NIH, USA
“Effectors vs Protectors: How Anti-Inflammatory Tissue Macrophages Maintain Tissue Homeostasis”

28.05.2019
Julia Esser-von Bieren, PhD
Center of Allergy & Environment (ZAUM), Technische Universität and Helmholtz Zentrum München
„Regulation of the arachidonic acid metabolism during type 2 immune responses“

25.06.2019
Prof. Ulrich Schaible
Forschungszentrum Borstel, Leibniz Lungenzentrum
„Host-directed therapy approaches in tuberculosis“

02.07.2019
Prof. Till Strowig
Dept. of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig
“Investigating the interplay of microbiota and host: From bugs to phenotypes“

09.07.2019
Prof. Sebastian Zeißig
Medizinische Klinik I – Universitätsklinikum Dresden
„Calcineurin and NFAT in the regulation of intestinal tumor development“

30.07.2019
Dr. Andrew Clark
Institut Curie, Paris, Frankreich
„Collective cell dynamics in intestinal cancer and homeostasis“

02.08.2019
Dr. Kilian Schober
Institut für medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München
„Re-directing T cells through advanced genetic engineering of T cell receptors for therapy“

15.10.2019
Prof. Jörg Köhl
Institute for Systemic Inflammation Research, Universität zu Lübeck
„Non-canonical functions of complement in inflammatory diseases“

22.10.2019
Prof. David Hildeman
Cincinnati Children’s Hospital Medical Center
„A novel Tfh population accumulates with age and links inflammation with age-related immune suppression“

29.10.2019
Prof. Alexander Visekruna
Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Philipps-Universität Marburg
„Regulation of the mucosal immune system by dietary and microbial factors“

05.11.2019
Dr. Tim Lämmermann
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)
„Navigation and communication strategies of innate immune cells in inflamed and infected tissues“

12.11.2019
Dr. Elvira Mass
Lehrstuhl für Genetik, Department Biologie, FAU
„Dissecting myeloid cell biology – from development to disease“

26.11.2019
Prof. Oliver Pabst
Institut für Molekulare Medizin, Universitätsklinikum RWTH Aachen
„Modulation of adaptive immunity by the gut microbiota“

03.12.2019
Dr. Andreas Hutloff
Chronische Immunreaktionen, Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
„T cell / B cell interactions in chronically inflamed tissues“

16.01.2018
Prof. Ivan Dikic
Institut für Biochemie II, Universtitätsklinikum Frankfurt
„Catalysis and Inhibition of Phosphoribosyl-dependent Ubiquitination“

23.01.2018
Prof. Burkhard Ludewig
Institut für Immunbiologie, Kantonspital St. Gallen, Schweiz
„Stromal cell – innate lymphoid cell interaction“

30.01.2018
Prof. Markus Feuerer
RCI Regensburger Centrum für Interventionelle Immunologie, Regensburg
„Tissular regulatory T cells“

10.04.2018
Prof. Thomas Tüting
Universitätsklinikum der Otto-Von-Guericke-Universität Magdeburg
„The role of neutrophils in melanoma pathogenesis and resistance to immunotherapy“

17.04.2018
Dr. Antigoni Triantafyllopoulou
Department of Rheumatology and Clinical Immunology, Charité – University Medical Centre Berlin
„DNA damage signals instruct macrophage differentiation in granulomatous diseases“

24.04.2018
Prof. Nicola Gagliani
General, Visceral and Thoracic Surgery Department, University Medical Center Hamburg-Eppendorf
„T cell functional heterogeneity and tissue-resident memory cells: understanding immune homeostasis and its underlying mechanisms“

08.05.2018
Prof. Reinhold Förster
Medizinischen Hochschule Hannover
„Homing of immune cells via afferent lymphatics“

15.05.2018
Prof. Wolfgang Kastenmüller
Institute of Experimental Immunology (IEI), University of Würzburg
„Concepts of T cell activation from a spatiotemporal perspective“

29.05.2018
Prof. Andreas Müller
Institute of Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg
„In vivo biosensors for functional analysis of host-pathogen interaction dynamics“

05.06.2018
Prof. Andrew MacDonald
Manchester Collaborative Centre for Inflammation Research (MCCIR), University of Manchester, UK
„Dendritic cells and macrophages in promotion and regulation of Type 2 inflammation“

12.06.2018
Prof. Séverine Vermeire
Department of Gastroenterology, University hospitals Leuven, Belgien
“Novel therapeutic opportunities in IBD and where to place them“

25.06.2018
Dr. Joanne Reed
Garvan Institute of Medical Research, Sydney, Australia
„Single cell analysis of self-reactive B cells in Autoimmune Disease“

26.06.2018
Assoc. Prof. Daniel Christ
Garvan Institute of Medical Research, Sydney, Australia
„Engineering antibody and T-cell specificity in vitro and in vivo“

03.07.2018
Prof. Annemiek van Spriel
Department of Tumor Immunology, University of Nijmegen, Niederlande
„Tetraspanins: molecular organizers of the immune cell surface“

10.07.2018
Prof. Eyal Gottlieb
Technion – Israel Institute of Technology, Haifa, Israel
„Identifying and exploiting cancer’s metabolic liabilities“

11.09.2018
Prof. Jens Titze
Medizinische Klinik 4, UK Erlangen, Duke-National University of Singapore, Duke University Medical Center, Durham, USA
„Using immune cells to understand salt and water metabolism“

16.10.2018
Prof. Stephan Bischoff
Institut für Ernährungsmedizin, Universität Hohenheim
„Intestinal barrier function in health and disease – from mouse to man“

23.10.2018
Prof. Klaus-Dieter Fischer
Institut für Biochemie und Zellbiologie, Universitätsklinikum Magdeburg
„B cell migration and calcium: How MZBs migrate towards shear flow and how mature B cells remove calcium through only one extrusion pump“

30.10.2018
Univ.-Prof. Birgit Sawitzki
Charité – Universitätsmedizin Berlin, Institut für Medizinische Immunologie
„Expression pattern and control by inhibitory receptors of T helper cell subsets“

06.11.2018
Florian Gärtner, PhD, MD
Medizinische Klinik und Poliklinik I, LMU München
„Platelets on the move – boosters of innate immunity“

13.11.2018
Prof. Daniel Pinschewer
Departement Biomedizin, Universität Basel, Schweiz
„Humoral immune defense in persistent viral infection“

20.11.2018
Prof. Detlef Schuppan
Institut für Translationale Immunologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz
„Nutrition and Autoimmunity: Wheat, ATI and Inflammation“

27.11.2018
Prof. Claus Cursiefen
Zentrum für Augenheilkunde, Universität zu Köln
„Corneal lymphangiogenesis as model for transplant immunology and tumor metastasis“

04.12.2018
Prof. Martin Zenke
Helmholtz Institute for Biomedical Engineering, Uniklinik Aachen, RWTH
“iPS cells for studying DC and leukemia”

18.12.2018
Dr. Marcus Conrad
Helmholtz Zentrum München
„Ferroptosis mechanisms in health and disease“

10.01.2017
Prof. Andrea Alimonti
Institute of Oncology Research, Bellinzona, Switzerland
„Reprogramming the tumor immune response for „pro-senescence“ therapy for cancer“

17.01.2017
Prof. Matthias Peipp
Sektion für Stammzell- und Immuntherapie, Christian-Albrechts-Universität zu Kiel
„Antibody Engineering to Improve Immunotherapy of Cancer“

31.01.2017
PD Dr. Gernot Schabbauer
Institute of Physiology, Medical University of Vienna, Austria
„PI3K and PTEN at the interface of innate and adaptive immunity“

02.05.2017
Prof. Matthias Tenbusch
Klinische und Molekulare Virologie, Universitätsklinikum Erlangen, FAU
„Gene-based vaccines against respiratory tract infections“

09.05.2017
Univ.-Prof. Mathias Hornef
Institut für Medizinische Mikrobiologie, Universitätsklinik der RWTH Aachen
“Ontogeny of the intestinal mucosal host response to infection”

23.05.2017
Prof. Christian Schulz
Klinikum der Universität München, Ludwig-Maximilians-Universität München
„Macrophage development – does origin matter?“

30.05.2017
Prof. Alfred Zippelius
Department of Biomedicine, University Hospital Basel, Schweiz
„Cancer Immunotherapy: Strategies for personalization and combination approaches“

13.06.2017
PD Dr. Stella Autenrieth
Universitätsklinikum Tübingen
„Modulation of dendritic cells by bacterial pathogens“

20.06.2017
Prof. Martin Staege
Universitätsklinikum Halle (Saale)
„Gene Expression Music applications in immunology and cancer research“

27.06.2017
Prof. Christian Münz
Institute of Experimental Immunology, University of Zürich, Schweiz
„Infection and immune control of human tumor viruses in vivo“

11.07.2017
Prof. Christoph Wilhelm
Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn
„Metabolic Regulation of ILC Mediated Barrier Immunity“

18.07.2017
Prof. Hanspeter Pircher
Institute for Immunology, University Medical Center Freiburg
„Antibodies and tissue-resident memory T cells in LCMV infection“

17.10.2017
Prof. Michael Sieweke
Centre d’Immunologie de Marseille Luminy, Marseille, Frankreich
„Stem cell like mechanisms of macrophage self renewal“

24.10.2017
Dr. Mario Zaiss
Medizinische Klinik 3, Universitätsklinikum Erlangen, FAU
„Gut bacterial metabolites and inflammatory diseases“

07.11.2017
Prof. Daniela Finke
Universitäts-Kinderspital beider Basel, Schweiz
„License to operate – new insights into the regulation of ILC immune functions“

14.11.2017
Prof. Marc Dalod
Centre d’Immunologie de Marseille Luminy, Marseille, Frankreich
“Deciphering how immune responses against infections or cancer are shaped by the cell types and states of mononuclear phagocytes”

05.12.2017
Prof. Steffen Jung
Weizmann Institute of Science, Rehovot, Israel
„Macrophage strategies in gut and brain“

12.12.2017
Prof. Andrew Mellor
Institute of Cellular Medicine, Newcastle University, UK
„Exploiting DNA as an immune adjuvant to treat cancer & autoimmune syndromes“

12.01.2016
Filip Swirski, PhD
Harvard Medical School, Boston, USA
Growth factors link B cells with macrophages in inflammation and metabolism

19.01.2016
Dr. Helmut Jonuleit
Department of Dermatology, Johannes Gutenberg-University Mainz
IL-6 modifies immunoregulation of T cell responses in Multiple Sclerosis

26.01.2016
Dr. Chiara Romagnani
Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin
Adaptive traits of NKG2C+ NK cell expansions in HCMV seropositive individuals

02.02.2016
Prof. Ernst Werner
Innsbruck Medical University
Center for Chemistry and Biomedicine (CCB)
Tetrahydrobiopterin: Impact on ischemia-reperfusion injury, allograft rejection and lipid metabolism

12.04.2016
Prof. Marina Kreutz
University Hospital Regensburg
„Immunomodulation by lactic acid“

19.04.2016
Prof. K. Lenhard Rudolph
Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut e.V. (FLI)
“Hematopoietic Stem Cell Aging and Lymphopoiesis“

26.04.2016
Tobias Fuchs, PhD
Universitätsklinikum Hamburg-Eppendorf
„Neutrophil Extracellular Traps – A Link Between Inflammation And Thrombosis“

03.05.2016
Prof. Edward Pearce
Max-Planck-Institut für Immunbiologie und Epigenetik, Freiburg
„Metabolic reprogramming in innate immune cell activation“

10.05.2016
Dr. Andreas Schlitzer
LIMES-Institute, University of Bonn
„Redefining Dendritic cell development – one cell at a time“

24.05.2016
Prof. Alexandra Trkola
Institut für Medizinische Virologie, Universität Zürich, Schweiz
„Virus, Host, and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction“

31.05.2016
Dr. Frank van de Veerdonk
Radboud University Medical Center, Nijmegen, The Netherlands
„From basic immunology to novel treatment strategies in aspergillosis“

14.06.2016
Prof. Christina Zielinski
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München
„Regulation of human T helper cell subsets by the microenvironment in health and disease“

21.06.2016
Prof. Patrick Bäuerle
MPM Capital, Cambridge Office
„T Cell-engaging Antibodies for Cancer Therapy“

28.06.2016
Prof. Thomas Weichhart
Medizinische Universität Wien
„mTOR and macrophage homeostasis“

12.07.2016
Martin Kriegel, MD, PhD
Yale School of Medicine, New Haven, USA
„T and B Cell Cross-reactivity in the Human Autoimmune Microbiome“

14.10.2016
Prof. Jacques Miller
Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
„Thymus function revealed“

18.10.2016
Prof. James J. Lee
Mayo Clinic, Scottsdale, Arizona, USA
„Eosinophils in Health and Disease: Regulators of Local Tissue Immune Responses“

25.10.2016
Prof. Nicola Harris
École polytechnique fédérale de Lausanne, Switzerland
„The multifaceted roles of B cells in helminth immunity“

15.11.2016
Prof. Knut Schäkel
Universitäts-Hautklinik, Heidelberg
„Identity and pro-inflammatory function of human 6-sulfo LacNAc (slan) dendritic cells“

22.11.2016
Univ.-Prof. Tom Lüdde
Universitätsklinikum RWTH Aachen
„Programmed Cell Death Pathways in Liver Disease and Hepatokarzinogenesis“

29.11.2016
Prof. Bernd Schmeck
Philipps-Universität Marburg, Klinik für Pneumologie
„Modeling RNA-networks in host-pathogen interaction“

06.12.2016
Prof. Paul Crocker
School of Life Sciences, University of Dundee, UK
„Regulation of neutrophil and macrophage functions by the murine inhibitory lectin, Siglec-E“

13.12.2016
Prof. Nicolas Fasel
Center for Immunity and Infection, University of Lausanne, Switzerland
„Metastatic leishmaniasis“

13.01.2015
David Sancho, Ph.D.
CNIC- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain
Novel aspects on Regulation of Th1 immunity by Dendritic cells

42108
Prof. Michael Dustin
Kennedy Institute, Oxford, UK
Role of immunological synapse in T cell tolerance and priming

20.01.2015
PD Dr. Hans Christian Probst
Johannes Gutenberg University Mainz
Tolerogenic Dendritic Cells: Bridging dominant and cell autonomous mechanisms of peripheral tolerance

27.01.2015
Dr. Till Strowig
Helmholtz Center for Infection Research, Braunschweig
Living on the edge – The intestinal microbiota and local inflammatory responses

23.02.2015
Prof. Sankar Ghosh
Columbia University, NY, USA
Regulation of NF-kB in inflammation and Immunity

14.04.2015
Dirk Baumjohann, Ph.D.
Ludwig-Maximilians-Universität (LMU) München
MicroRNA-mediated regulation of T helper cell differentiation and plasticity

21.04.2015
Dr. Anca Dorhoi
Max Planck Institute for Infection Biology Department of Immunology, Berlin
The double-edged sword of inflammation in tuberculosis

28.04.2015
Dr. Mohini Gray
The Queen’s Medical Research Institute, Edinburgh, UK
Immune Tolerance to Apoptotic cells is mediated by Self Reactive Innate-Like B cells

12.05.2015
Prof. Warren Strober
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA
The Role of E-Proteins in Th17 and Regulatory T cell induction

18.05.2015
Prof. Balbino Alarcón
Universidad Autónoma de Madrid, Spain
Clustering, Conformational Changes and Cooperativity in the T-cell Receptor

28.05.2015
Joke den Haan, Ph.D.
VU University Medical Cente, Amsterdam, The Netherlands
CD169+ macrophages and dendritic cells: Collaboration results in efficient induction of adaptive immune responses

02.06.2015
Prof. Ari Waisman
Institut für Molekulare Medizin, Universitätsmedizin der Johannes Gutenberg-Universität Mainz
What makes Th17 cells pathogenic?

09.06.2015
Prof. Andrew Macpherson
Gastroenterology & Mucosal Immunology, Inselspital Bern, Switzerland
When and where are our bodies influenced by our intestinal microbes?

16.06.2015
Hendrik Streeck, M.D., Ph.D.
HIV Diagnostics and Reference Laboratory, Silver Spring, USA, ab Juni am Uniklinikum Essen
B cell and Tfh dynamics in HIV pathogenesis and vaccination

23.06.2015
Prof. Oliver Kurzai
Leibniz-Institute for Natural Products Research and Infection Biology – Hans-Knoell-Institute, Jena
The role of neutrophils in invasive fungal infections

30.06.2015
Prof. Thomas Decker
MAX F. PERUTZ LABORATORIES, Wien, Austria
From Cosmos to Chaos-interferon signaling gets messy

07.07.2015
Prof. Marcus Thelen
Università della Svizzera italiana, Institute for Research in Biomedicine, Bellinzona, Switzerland
ACKR3 (CXCR7): role in B cell responses

21.07.2015
Prof. Jan Tuckermann
Universität Ulm
Modes of GR action reversed: Synergistic Gene Induction limits Inflammation and Gene Repression affects Bone

08.10.2015
Dr. Simone Häberlein
Leiden University Medical Center, Leiden, The Netherlands
A „worm pill“ against asthma? Induction of regulatory B cells by helminth antigens and their application in experimental allergic asthma therapy

13.10.2015
Prof. Peter van Endert
INSERM, Hôpital Necker, Paris, France
Endosome dynamics and antigen presentation by dendritic cells

20.10.2015
Prof. Thomas Brocker
Institute for Immunology, Ludwig-Maximilians-Universität Munich
Tissue-specific control of immunity and tolerance by Dendritic Cells

27.10.2015
Prof. Andrés Hidalgo
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Functional interactions of neutrophils with the bone marrow

10.11.2015
Prof. Robert Zeiser
Klinik für Innere Medizin I, Universitätsklinikum Freiburg
Pathomechanisms of intestinal acute GvHD

17.11.2015
Univ.-Prof. Dr. Tobias Bopp
Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz
Context- and Tissue-specific Regulation of Immunity and Tolerance by Protein Kinase CK2

24.11.2015
Prof. Irmgard Förster
LIMES-Institut, Bonn
Environmental control of immune responses through the AhR/AhRR sensory system

08.12.2015
Dr. Manuel Koch
Max Planck Institute for Infection Biology, Berlin
The role of Helicobacter pylori in the development of gastric adenocarcinoma

15.12.2015
Prof. Marc Schmidt-Supprian
Technische Universität München
NF-kB activation in Autoimmunity and Lymphomagenesis

07.01.2014
Dr. Marcin Kaminski
DKFZ Heidelberg
Mitochondrial oxidative signaling in T cell activation: role for Warburg effect and a new ADP-dependent glucokinase

14.01.2014
Prof. Nathaniel R. Landau, Ph.D.
Department of Microbiology, New York, USA
Restriction of HIV-1 by SAMHD1: Starving the Virus

21.01.2014
Dr. Georg Gasteiger
Memorial Sloan-Kettering Cancer Center, New York, USA
Help and Regulation: Interactions of adaptive and innate lymphocytes

28.01.2014
Anja Fröhlich, Dr. sc.
Charité Universitätsmedizin Berlin
Cytokine-mediated regulation of antiviral CD8 T cell responses

04.02.2014
Prof. Marcus Groettrup
Institut für Immunologie, Konstanz
The immunoproteasome in the pathogenesis of autoimmune diseases

06.02.2014
Prof. Brigitta Stockinger
National Institute for Medical Research, London, UK
Environmental triggers of inflammatory immune responses

11.02.2014
Dr. Ildiko Dunay
Universitätsklinikum Magdeburg
Role of monocytes in Toxoplasma infection

25.02.2014
Prof. Andrew McKenzie
Cambridge Biomedical Campus, Cambridge, UK
Type-2 innate lymphoid cells (ILC2) in infection and allergy

08.04.2014
Dr. Fulvia Ferrazzi
Lehrstuhl für Humangenetik, Universitätsklinikum Erlangen
Systems biology approaches to elucidate gene regulatory networks

29.04.2014
Prof. Victor Tybulewicz
MRC National Institute for Medical Research, London, UK
B cell survival and tonic signalling from the BCR

06.05.2014
Prof. Manfred Kopf
Institute of Molecular Health Sciences ETH Zürich, Switzerland
Alveolar Macrophage Development and Function in Respiratory Viral Infection

08.05.2014
Assoz. Prof. Dr. Patrizia Stoitzner
Department of Dermatology & Venereology, Innsbruck Medical University, Austria
Skin dendritic cells in tumor immunity: interesting targets for immunotherapy?

13.05.2014
Prof. Joachim Schultze
LIMES Institute, Genomics and Immunoregulation, Bonn
The spectrum of macrophage activation. Beyond the M1/M2 model

20.05.2014
Prof. Felix Randow
MRC Laboratory of Molecular Biology, Cambridge, UK
Autophagy in host-pathogen interactions

27.05.2014
Prof. Jan Rupp
Med. Mikrobiologie und Hygiene, Med. Klinik III, Lübeck
Interplay between hypoxia/HIF-1 related signaling with metabolic and inflammatory reactions in intracellular chlamydial infections

03.06.2014
Dr. Gijs Versteeg
Max F. Perutz Laboratories (MFPL), Vienna, Austria
TRIMmunity: The roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity

17.06.2014
Prof. Sai Reddy
ETH Zürich, Technology Department of Biosystems Science & Engineering, Basel, Switzerland
Applying systems immunology for the analysis of B cells and antibody repertoires

24.06.2014
Prof. Wolfgang Kastenmüller, MD
Institutes of Molecular Medicine and Experimental Immunology (IMMEI), University of Bonn
Pathogen Defense in the Lymph Node – From Innate to Adaptive Immunity

01.07.2014
Vera Martins, PhD
Institute for Immunology, University Hospital Ulm
Cell competition is a tumor suppressor mechanism in the thymus

08.07.2014
Prof. Dr. med. Stephan Ehl
CCI – Centrum für Chronische Immundefizienz, Universitätsklinikum Freiburg
New lessons from human genetic disorders of T cell immunity

20.10.2014
Dr. Peter Murray
St. Jude Children’s Research Hospital, Memphis, USA
Amino acid metabolism links immunoregulation and immune pathology

21.10.2014
Dr. Dietmar Zehn
Centre hospitalier universitaire vaudois (CHUV), Lausanne, Switzerland
Linking functional diversity and TCR affinity in chronic infections

28.10.2014
Prof. Heinrich Körner
Menzies Research Institute Tasmania, Australia
A New Function For An Old Acquaintance? Dissecting the Roles of TNF in Monocyte Differentiation.

04.11.2014
Prof. Victor Tybulewicz
MRC National Institute for Medical Research, London, UK
Signals controlling B cell survival and T cell adhesion

11.11.2014
Prof. Cornelis Verweij
VU University Medical Center Amsterdam,The Netherlands
Clinical relevance of tertiary lymph node structures and interferon system in rheumatoid arthritis.

18.11.2014
Prof. Florian Greten
Georg-Speyer-Haus, Institut für Tumorbiologie und experimentelle Therapie, Frankfurt a. M.
NF-kappaB and Stat3 control cell plasticity in intestinal tumorigenesis

25.11.2014
Prof.Burkhard Becher
University of Zurich, Institute of Experimental Immunology, Switzerland
How T cells instruct myeloid cells in tissue inflammation!

02.12.2014
Prof. Alexander Rösch
Universitätsklinikum Essen
The cancer stem cell controversy and phenotypic plasticity in melanoma: Implications for the clinics

09.12.2014
Prof. Salomé LeibundGut-Landmann
Institute of Microbiology, ETH Zürich, Switzerland
Interleukin-17-mediated host defense against fungal infection

08.01.2013
Prof. Martin Trepel
Universitätsklinikum Hamburg-Eppendorf
Characterization and targeting of cell-type-specific receptors in cancer and normal tissues.

09.01.2013
Prof. Alastair Watson
University of East Anglia, Norwich, UK
Intestinal Inflammation and Barrier Function

15.01.2013
Prof. Veronika Sexl
Veterinärmedizinische Universität Wien, Austria
Nk cell dependent tumor surveillance – STATs in the spotlight

22.01.2013
Prof. Manfred Lutz
Institute of Virology and Immunobiology, Julius-Maximilians-Universität Würzburg
Myeloid-Derived Suppressor Cell function shaped by GM-CSF licensing and mycobacterial activation

29.01.2013
PD Dr. Frederik Boernke
Department of Biochemistry, Friedrich-Alexander-Universität
Innate Immunity in Plants and its Subversion by bacterial Effectors

05.02.2013
Prof. Donald Olins and Prof. Ada Olins
University of New England, Maine, USA
The Deformable Granulocyte Nucleus and Epichromatin

12.04.2013
Prof. Eric Vivier
Centre d’Immunologie de Marseille-Luminy, Marseille, France
Natural Killer cells, Innate Lymphoid cells and Innate Imumnity

16.04.2013
Dr. Anita Kremer
Medizinische Klinik 5, Universitätsklinikum Erlangen
HLA class II restricted minor histocompatibility antigens in graft-versus-leukemia effect and graft-versus-host disease

30.04.2013
Prof. Ian Mackenzie
Barts and The London School of Medicine and Dentistry, London, UK
Phenotypic switching of stem cells in head and neck cancers

07.05.2013
Prof. Ulf Dittmer
Institut für Virologie, Universität Duisburg-Essen
The role of regulatory T cells in chronic viral infections

14.05.2013
Paolo Dellabona, M.D., Ph.D.
San Raffaele Scientific Institute, Milano, Italy
Targeting leukemia by CD1 autoreactive T cell responses

28.05.2013
Dr. Claudia Waskow
DFG Center for Regenerative Therapies (CRTD), Dresden
Opening-up the niche for human and mouse hematopoietic stem cells

11.06.2013
Prof. Carlos Ardavin
Department of Immunology & Oncology, National Center for Biotechnology/CSIC, Madrid, Spain
Production of type I interferon by inflammatory dendritic cells in response to Candida albicans infection

25.06.2013
Prof. Dirk Busch
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, TU München
Effector/memory CD8+ T cell differentiation at the single cell level

02.07.2013
Prof. Stipan Jonjić
Department for Histology and Embryology, University of Rijeka, Croatia
Expression of NKG2D ligand RAE-1 by mouse cytomegalovirus enhances virus immunogenicity and vaccine efficacy

09.07.2013
Prof. Markus Manz
Experimental Hematology Lab, University Hospital Zurich, Switzerland
Hematopoietic Homeostasis in Steady-State and Inflammation

14.10.2013
Dr. Guy Shakhar
Department of Immunology, Weizman Institute of Science, Revohot, Israel
Insights from live 2-photon imaging of tumors: Angiogenesis promotes CTL dissemination and cytotoxicity

15.10.2013
Prof. Axel Roers
Institut für Immunologie, TU Dresden
Mouse models for Aicardi-Goutières syndrome: Does the innate response to endogenous retroelements cause autoimmunity?

22.10.2013
Prof. Dirk Elewaut
Division of Rheumatology, University of Ghent, Belgium
Pathways leading to chronicity of disease in spondyloarthritis

05.11.2013
Samuel Wagner, PhD
Eberhard Karls University Tübingen
Structure, assembly, and function of a bacterial nanosyringe

11.11.2013
Prof. Aaron J. Marshall
Departments of Immunology, Biochemistry and Medical Genetics, University of Manitoba, Canada
Phosphoinositide signaling pathways in B lymphocytes

12.11.2013
Prof. Bernhard Brüne
Institut für Biochemie, Goethe-University Frankfurt
Macrophages in the tumor microenvironment under the control of hypoxia and lipids

19.11.2013
Dr. Philipp Yu
Institut für Immunologie, Philipps-Universität Marburg
IgE in Anaphylaxis, but is there a function beyond Allergy?

26.11.2013
Prof Dr. Elke Krüger
Charité Universitätsmedizin Berlin, Institute of Biochemistry
The ubiquitin proteasome system at the crossroads of oxidative stress and immune responses

10.12.2013
Prof. Nikolaus Romani
Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Innsbruck, Austria
Langerhans cells & more: attempts to harness their immunological functions

17.12.2013
Dr. Hedda Wardemann
Max Planck Institute for Infection Biology, Berlin
Single cell analysis of B cell repertoires

10.01.2012
Dr. Benjamin Rhodes
King’s College London, UK
SLE genetics – lots of genes but what next?

17.01.2012
Prof. Ofer Mandelboim
Hebrew University Hadassah Medical School, Israel
Proteins and miRNA-mediated Regulation of NK Cell Activity

24.01.2012
Prof. Robert M. Strieter
University of Virginia, Charlottesville, USA
The role of CXC chemokines in Lung Cancer

31.01.2012
Prof. Tariq Enver
University College London Cancer Institute, London, UK
Title unknown

07.02.2012
Prof. Francesca Granucci
Department of Biotechnology and Bioscience, University of Milano-Bicocca, Italy
The Multifaceted Roles of CD14 in Innate Immunity

20.03.2012
PD Dr. Immo Prinz
Medizinische Hochschule Hannover
Is there a role for innate or adaptive gamma/delta T lymphocytes in the immune response to cytomegalovirus?

28.03.2012
Prof. Jean-Laurent Casanova
The Rockefeller University, New York, USA
Toward a genetic theory of infectious diseases

24.04.2012
PD Dr. Beate Winner
IZKF Nachwuchsgruppe, Universität Erlangen
Modeling neurodegenerative disease using pluripotent stem cells

08.05.2012
Prof. Ignacio Melero
University of Navarra, Pamplona, Spain
Immunostimulatory monoclonal antibodies directed to CD137

15.05.2012
Prof. Thomas Brocker
Institut für Immunologie, LMU München
Dendritic cells and the induction of T cell tolerance

22.05.2012
Prof. Falk Weih
Leibniz-Institut für Altersforschung, Fritz-Lipmann-Institut, Jena
On T-cell responses in the aortic wall of hyperlipidemic mice and how lymphotoxin signaling regulates adipogenesis

05.06.2012
Prof. Oliver Pabst
Medizinische Hochschule Hannover
Generating IgA Repertoire Diversity in the Intestine

12.06.2012
PD Dr. Heike Weighardt
Leibniz-Institut für umwelt- medizinische Forschung, Düsseldorf
Interactions between the environment and the innate immune system

19.06.2012
Prof. Thomas Hünig
Lehrstuhl für Immunologie, Universität Würzburg
Oligodendrocytes enforce immune privilege of the non-infected brain by deleting the peripheral CD8 T-cell repertoire of auto-reactive cells

26.06.2012
Prof. Alexander Dalpke
Dept. of Medical Microbiology and Hygiene, Heidelberg
Lights on, lights off – signal induction and signal termination in innate immunity

03.07.2012
Prof. Martin Leverkus
Klinik für Dermatologie, Venerologie und Allergologie, Universität Heidelberg
The Ripoptosome, a novel signalling platform regulating apoptosis and necroptosis

10.07.2012
Prof. Adrian Hayday
Immunology, Infection and Inflammatory Disease King´s College London, UK
Lymphoid stress-surveillance: the benefits and challenges of useful autoimmunity

17.07.2012
Prof. A. Graham Pockley
Immunobiology Research Group, Department of Oncology, University of Sheffield, UK
The contrasting immunoregulatory properties of heat shock proteins and their influence on disease processes and therapeutic potential

09.10.2012
Prof. David Allman
Department of Pathology and Laboratory Medicine, University of Pennsylvania, USA
Maintaining serum antibody responses

16.10.2012
Dr. Agnès Lehuen
Institut National de la Santé et de la Recherche Médicale, L’Université Paris–Descartes, France
Regulatory role of NKT cells in viral infection and autoimmune diabetes

23.10.2012
Prof. Rick Maizels
Institute of Immunology and Infection Research, University of Edinburgh, UK
Immune regulation by helminths : impact on allergy and immunity

06.11.2012
Gerard Eberl, PhD
Lymphoid Tissue Development Unit, Institut Pasteur, Paris, France
Innate lymphoid cells and intestinal homeostasis

13.11.2012
Prof. Ludger Klein
Institute for Immunology, Ludwig-Maximilians-Universität München
Thymic epithelium and central T cell tolerance

27.11.2012
Prof. Dolores Schendel
Helmholtz Zentrum München, Institut für Molekulare Immunologie
Selection and use of high-affinity T cell receptors in designer lymphocytes for adoptive cell therapy

04.12.2012
Prof. Aline Bozec
Medizinische Klinik 3, Universitätsklinikum Erlangen
The multiple functions of Fra-2/ AP-1 transcription factor: from bone biology to metabolism and inflammation

11.12.2012
Prof. Ines Batinic-Haberle
Duke University, Durham, NC, USA
The therapeutic effects of Mn porphyrins in radiation, cancer and central nervous system injuries

18.12.2012
Dr. Ralf Linker
Universitätsklinikum Erlangen
New insights into disease mechanisms in MS: on the way to translational medicine

11.01.2011
Dr. Sebastian Amigorena
INSERM U932 Immunité et Cancer, Institut Curie, Paris, France
Antigen presentation and T cell activation by dendritic cells

18.01.2011
Dr. Erik Glocker
Royal Free Hospital and University College Medical School, London, UK
Monogenic causes for early-onset inflammatory bowel disease

25.01.2011
Prof. Kasper Hoebe
Cincinnati Children’s Hospital, OH, USA
Understanding the genetic basis of immune deficiencies: a small scale ENU mutagenesis approach

01.02.2011
Caetano Reis e Sousa
Cancer Research UK, London, UK
Innate regulation of adaptive immunity by dendritic cells

08.02.2011
Prof. Alf Hamann
Dt. Rheumaforschungszentrum, Berlin
Epigenetic imprinting of T cell homing and function

12.04.2011
Prof. Michael Karin
University of California, San Diego, CA, USA
Control of Tumor Progression and Metastasis by Lymphocyte-Produced Cytokines

03.05.2011
Prof. Bernard Malissen
Marseille, France
Disentangling the complexity of the dendritic cell networks present in the skin and the thymus

17.05.2011
Prof. Dr. med. Hendrik Veelken
Leiden, University Medical Center, The Netherlands
Mutual Interactions between Malignant Lymphomas And The Immune System: Prospects for Novel Therapeutic Interventions

24.05.2011
Prof. Otto Haller
University of Freiburg
Innate Immunity to Influenza Viruses

31.05.2011
Prof. Federica Sallusto
Institute for Research in Biomedicine, Bellinzona, Switzerland
Dendritic cells and the demanding task of priming T cell responses

21.06.2011
Prof. Steffen Stenger
Universität Ulm
Effector Mechanisms in Immunity to Tuberculosis in Humans

28.06.2011
Prof. Thomas Korn
Klinikum rechts der Isar Technische Universität München
T Cellular Players in Autoimmune Neuroinflammation

04.07.2011
Prof. Hans Schöler
MPI für molekulare Biomedizin, Münster
Induction of Pluripotency: 20 Years of Research

05.07.2011
Prof. Thomas Schüler
Charité Berlin
The Regulation of Intestinal Homeostasis by Interleukin-7

12.07.2011
Prof. Arndt Borkhardt
Universität Düsseldorf
EBV-Associated Lymphproliferation Caused by Inherited, Primary T-Cell Deficiency

26.07.2011
PD Dr. Jens Titze
IZKF Nachwuchsgruppe II, Universität Erlangen
Macrophages Are Essential for Electrolyte and Blood Pressure Homeostasis

25.10.2011
Prof. Andreas Diefenbach
Universitätsklinikum Freiburg
Development and Function of Innate Lymphocytes

08.11.2011
Prof. Thomas Gramberg
Institut für Virologie, Universitätsklinikum Erlangen
SIV Vpx protects divergent retroviruses from a SAMHD-1 mediated restriction in macrophages

15.11.2011
Prof. Eicke Latz
Institute of Innate Immunity, University Hospital University Bonn
Mechanisms of Inflammasome Activation in Inflammatory Diseases

22.11.2011
Prof. Manolis Pasparakis
Universität zu Köln
Epithelial Regulation of Intestinal Inflammation and Cancer

29.11.2011
Prof. Christopher D. Gregory
MRC Centre for Inflammation Research, Edinburgh, UK
The Role of Apoptosis in Conditioning the Microenvironment of Tumours

06.12.2011
Prof. Michael Sixt
Institute of Science and Technology Austria, Klosterneuburg
Mechanisms of Leukocyte Chemotaxis

12.12.2011
Prof. Kenneth Murphy
Washington University, St. Louis, MO, USA
Batf factors in immune function

20.12.2011
Prof. Max Löhning
DRFZ Berlin
Generation, maintenance and reprogramming of immunological memory

12.01.2010
PD Dr. Olaf Utermöhlen
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene der Universität Köln
Saure Sphingomyelinase im Immunsystem

19.01.2010
Prof. Reinhold Förster
Institut für Immunologie Medizinische Hochschule Hannover
Die Bedeutung von sekundären und tertiären lymphatischen Organen für die Immunität in Respirationstrakt

26.01.2010
Dr. Sjoerd van der Burg
Leiden University Medical Center, The Netherlands
Immune correlates of success and failure of therapeutic vaccination

02.02.2010
Prof. Silvia Bulfone-Paus
Leibniz-Zentrum Borstel
Cellular and cytokine interactions in health and disease

09.02.2010
Prof. Luigina Romani
Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Universität Perugia, Italy
The Immunology of fungi: the story so far

23.02.2010
Dr. Alexander Zarbock
Universität Münster
Die Selektin vermittelte Aktivierung von Leukozyten (Selectin-mediated leukocyte activation)

02.03.2010
Klaus Okkenhaug
Babraham Institute Cambridge, UK
Role of PI3K in immunity and inflammation

09.03.2010
Dr. Lukas Neukomm
University of Zurich, Institute of Molecular Biology, Switzerland
Regulation of cell corpse removal – a worm´s point of view

27.04.2010
Prof. Edgar Meinl
MPI München
Humoral immunity in Multiple Sclerosis

04.05.2010
Dr. Ana Maria Lennon-Duménil
Institut Curie, Paris, Framce
Spatio-temporal Regulation of Antigen Presentation and Dendritic Cell Migration

11.05.2010
Prof. Irving Weissman
Stanford University School of Medicine, CA, USA
Normal and Neoplastic Stem Cell

18.05.2010
Prof. Jérôme Galon
Cordeliers Research Center, Paris, France
Intratumoral immune reaction: a novel paradigm for colorectal cancer

01.06.2010
Prof. Thomas Blankenstein
Charité, Berlin
The power of adoptive T cell therapy

08.06.2010
Prof. Massimo Locati
University of Milan, Italy
Macrophage polarized activation: lessons from transcriptional profiling

15.06.2010
Prof. László Nagy
Universität Debrecen, Hungary
Nuclear hormone receptors link lipid metabolism and immune function in macrophages and dendritic cells

22.06.2010
Prof. Martin Krönke
Universität Köln
TNF Signaling and Regulation of ROS Production

29.06.2010
Prof. Ton Schumacher
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Dissecting and manipulating tumor-specific T cell immunity

06.07.2010
Prof. Jane McKeating
University of Birmingham, UK
The ins and outs of hepatitis C virus

13.07.2010
Prof. Muriel Moser
Université Libre de Bruxelles, Belgium
Control of T helper cell development by regulatory T cells in vivo

20.07.2010
Prof. Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris, France
How can chemotherapy represent an authentic cancer vaccine?

27.07.2010
Prof. Matthias Edinger
Klinikum der Universität Regensburg
Regulatory T cells in allogeneic stem cell transplantation

27.04.2010
Prof. Edgar Meinl
MPI München
Humoral immunity in Multiple Sclerosis

19.10.2010
Caroline Barisch
Universität Kassel
Lipid Droplets in Dictyostelium discoideum – a proteomics approach

26.10.2010
Prof. Dirk Busch
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, TU München
Primary T cells: A source for novel immunotherapies?

02.11.2010
Prof. Ulrich Koszinowski
Max von Pettenkofer-Institut, Virologie, LMU München
Much ado about almost nothing: A random approach to herpesvirus morphogenesis

09.11.2010
Prof. Gernot Achatz
Universität Salzburg, Austria
The Biology of IgE: Molecular Mechanisms Restraining Potentially Dangerous High Serum IgE Titres in vivo

16.11.2010
Prof. Hansjörg Schild
Universität Mainz
CD4 positive T cell subpopulations in the induction and control of adaptive immunity

21.12.2010
Prof. Ari Waisman, I.
Medizinische Klinik und Poliklinik Universität Mainz
New murine models to study inflammatory cytokines

13.01.2009
Prof. Christopher Tang
Imperial College London, UK
Generic mechanisms in Neisseiria meningitidis for Immune escape

20.01.2009
Prof. Thierry Walzer
Centre d’Immunologie Marseille-Luminy, France
Natural Killer cell development and trafficking

27.01.2009
Prof. Gerd Schmitz
Universitätsklinikum Regensburg
The Lipom

03.02.2009
Prof. Sigfried Weiss
Helmholtz Zentrum für Infektionsforschung, Braunschweig
Interaction of tumor colonizing bacteria with the immune system

10.02.2009
Prof. Thomas Böhm
Max-Planck-Institut für Immunbiologie Freiburg
The evolutionary history of the thymus and the adaptive immune system

17.02.2009
Prof. Luigina Romani
Department of Experimental Medicine University of Perugia, Italy
Tryptophane metabolism and immune response

20.03.2009
Pavel Kovarik, PhD
Max F. Perutz Laboratories University of Vienna, Austria
RNA decay in immune Homeostasis

04.03.2009
Dr. Bärbel Stecher
Institut für Mikrobiologie, Eidgenössische Technische Hochschule (ETH) Zürich, Switzerland
The gut flora and infections with enteropathogenic bacteria

08.04.2009
Dirk Hofreuter, Ph.D.
Yale University School of Medicine Boyer Center for Molecular Medicine, New Haven, USA
Metabolic diversity in Campylobacter jejuni influences tissue tropism during infection

28.04.2009
Dr. rer. nat. Laura Helming
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene TU München
Multinucleated giant cells and osteoclasts: The molecular basis of macrophage fusion

29.04.2009
Dr. Christiane Desel
Max-Planck-Institut für Infektionsbiologie, Berlin
Vaccination with recombinant (delta)ureC hly+ BCG induces a potent Th17 response

05.05.2009
Prof. Dr. Thomas Rudel
Lehrstuhl für Mikrobiologie, Theodor-Boveri-Institut für Biowissenschaften, Universität Würzburg
Bacterial infection targeting the host cell death machinery

12.05.2009
Teunis B.H. Geijtenbeek, Ph.D.
VU University Medical Center Amsterdam, Molecular Cell Biology and Immunology, The Netherlands
C-type lectin signalling in adaptive immunity and infections

19.05.2009
Hamida Hammad, Ph.D.
University Ghent Department of Internal Medicine, Belgium
Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma

26.05.2009
Johan van der Vlag, Ph.D.
Nijmegen Centre for Molecular Life Sciences, The Netherlands
Apoptotic blebs and apoptosis-modified autoantigens: Triggers leading to autoimmunity in Systemic Lupus Erythematosus

09.06.2009
Priv.-Doz. Dr. Florian M. Greten
Technische Universität München, 2. Medizinische Klinik, Klinikum rechts der Isar
NF-kappaB and Stat3 –from inflammation to colon cancer

16.06.2009
Prof. Dr. Günter J. Hämmerling
Deutsches Krebsforschungszentrum DKFZ Abt. Molekulare Immunologie, Heidelberg
Feedback control of dendritic cell homeostasis, and consequences for intrinsic T cell reactivity

23.06.2009
Prof. Dr. Rainer Haas
Max-von-Pettenkofer-Institut für Hygiene und medizinische Mikrobiologie, München
Helicobacter pylori, a paradigm for chronic infection and modulation of the host

30.06.2009
Prof. Dr. Jens-Michael Schröder
Klinik für Dermatologie, Venerologie und Allergologie, Kiel
Antimicrobial Peptides: Effector Molecules of the Local Host Defense System

02.07.2009
Prof. Dr. Andreas J. Bäumler
University of California at Davis Department of Medical Microbiology and Immunology School of Medicine, USA
Salmonella: life in the inflamed intestine

21.07.2009
Prof. Dr. Thomas Dörner
Bereich Klinische Hämostaseologie Charité Universitätsmedizin Berlin
Direct and indirect targeting of B cells

20.10.2009
Dr. Ahmed Sheriff
Charite Berlin
CRP as a therapeutic target: cardiac infarction therapy in pigs

27.10.2009
Prof. Willi Jahnen-Dechent
Universität Aachen
Bugs, dead cells, blood clots, mineral and lipid: Fetuin family-serum proteins play vital roles in cellular remodelling and systemic clearing of debris

03.11.2009
Prof. Carl Nathan
Cornell University New York, NY, USA
Chemotherapy of Infectious Disease Guided by Host-Pathogen Interactions

10.11.2009
Prof. Falk Hiepe
Charite Berlin
Memory plasma cells in autoimmunity

17.11.2009
Prof. Tim Sparwasser
TWINCORE GmbH Zentrum für Experimentelle und Klinische Infektionsforschung, Hannover
Novel approaches for vaccine design: Bypassing Treg activity enhances T cell-mediated immunity

24.11.2009
Prof. Wolfgang Herr
Universitätsklinikum Mainz
Separation GVHD-GVL by adding GVL-mediating T cells

01.12.2009
Dr. Martin Turner
The Babraham Institute, Cambridge, UK
Roles for RNA binding proteins during lymphocyte development and activation

08.12.2009
Dr. Jason Mercer
Institut für Biochemie Zürich, Switzerland
High-throughput Screening of Troy: In search of the Achilles‘ heel of Poxvirus Infection

15.12.2009
Prof. Laszlo Nagy
Universität Debrecen, Hungary
Nuclear hormone receptors link lipid metabolism and immune function in macrophages and dendritic cells

22.12.2009
Prof. Elke Pogge von Strandmann
Labor für Immuntherapie Klinik I für Innere Medizin Universität zu Köln
Stress inducible ligands and NK cell activation